Jul 1 |
Teva focus of FTC investigation over inhaler patents
|
Jun 28 |
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
|
Jun 25 |
Teva to pay $750M as part of tax deal with Israel
|
Jun 25 |
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
|
Jun 24 |
Teva launches authorized generic of Victoza for diabetes, cardiovascular treatment in the U.S.
|
Jun 24 |
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
|
Jun 24 |
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
|
Jun 22 |
Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?
|
Jun 15 |
U.S. drug shortages worsen to reach a decade high: report
|
Jun 14 |
Teva accuses Corcept of monopolizing the market for Korlym
|